Vanda Pharmaceuticals Inc.
VNDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001347178
No open-market purchases or sales by Vanda Pharmaceuticals Inc. insiders were filed in the last 90 days; 172 institutions reported holding it in 13F filings for Q2 2026, worth $304.1M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Vanda Pharmaceuticals Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Of which not filed for Q4 2024 | Q4 2024 | Change |
|---|---|---|---|---|
| Holders | 152 | 2 | 146 | −4 |
| Shares | 44.0M | 11.6K | 43.1M | −822.6K (−1.9%) |
| Value | $206.3M | $54.2K | $206.7M | +$455.1K (+0.2%) |
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 270,541 | $1.30M | 0.01% |
| Susquehanna Fundamental Investments, LLC | 254,845 | $1.22M | 0.02% |
| KLP Kapitalforvaltning AS | 135,400 | $648.6K | 0.00% |
| Marshall Wace, LLP | 80,800 | $387.0K | 0.00% |
| Empire Financial Management Company, LLC | 64,000 | $306.6K | 0.10% |
| Mackenzie Financial Corp | 50,012 | $239.6K | 0.00% |
| Qube Research & Technologies Ltd | 27,481 | $131.6K | 0.00% |
| Stonepine Capital Management, LLC | 25,000 | $119.8K | 0.10% |
| Zacks Investment Management | 15,471 | $74.1K | 0.00% |
| Police & Firemen's Retirement System of New Jersey | 14,529 | $69.6K | 0.00% |
| XTX Topco Ltd | 14,496 | $69.4K | 0.01% |
| Quantinno Capital Management LP | 10,012 | $48.0K | 0.00% |
| GF Fund Management Co. Ltd. | 1,224 | $5.86K | 0.00% |
| Northwestern Mutual Wealth Management Co | 900 | $4.31K | 0.00% |
| Group One Trading, L.P. | 858 | $4.11K | 0.00% |
| Skopos Labs, Inc. | 437 | $2.09K | 0.00% |
| R Squared Ltd | 140 | $671 | 0.00% |
| SBI Securities Co., Ltd. | 40 | $192 | 0.00% |
| True Wealth Design, LLC | 25 | $120 | 0.00% |
| IFP Advisors, Inc | 10 | $48 | 0.00% |
| Cassady Schiller Wealth Management, LLC | 10 | $48 | 0.00% |
Sold out (25)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Nantahala Capital Management, LLC | 1,593,516 | $7.47M |
| BML Capital Management, LLC | 228,500 | $1.07M |
| Empowered Funds, LLC | 228,287 | $1.07M |
| Meteora Capital, LLC | 90,900 | $426.3K |
| Winton Group Ltd | 72,465 | $339.9K |
| Susquehanna Portfolio Strategies, LLC | 52,547 | $246.4K |
| Panagora Asset Management Inc | 46,781 | $219.4K |
| Sherbrooke Park Advisers LLC | 42,207 | $198.0K |
| Virtus Investment Advisers, Inc. | 28,255 | $132.5K |
| US Bancorp | 27,244 | $127.8K |
| Envestnet Asset Management Inc | 25,496 | $119.6K |
| Corton Capital Inc. | 22,074 | $103.5K |
| Virtu Financial LLC | 21,713 | $102.0K |
| Boothbay Fund Management, LLC | 17,344 | $81.3K |
| Cornercap Investment Counsel Inc | 16,101 | $75.5K |
| Diversified Trust Co | 12,138 | $56.9K |
| Atria Investments LLC | 11,639 | $54.6K |
| ORG Wealth Partners, LLC | 8,469 | $39.7K |
| Gladius Capital Management LP | 5,500 | $25.8K |
| Capital Performance Advisors LLP | 303 | $1.42K |
| Signaturefd, LLC | 292 | $1.37K |
| Bokf, NA | 44 | $198 |
| GPS Wealth Strategies Group, LLC | 25 | $117 |
| National Bank of Canada | 2 | $9 |
| Avion Wealth | 140 | $0 |
Not filed for Q4 2024 yet (2)
Institutions that held Vanda Pharmaceuticals Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| AJOVista, LLC | 11,552 | $54.2K |
| Planning Capital Management Corp | 10 | $47 |